Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Neoplasms × Algorithms × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Thrombocytopenia 1 Stomach Neoplasms 1 Neutropenia 1 Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Appendiceal Neoplasms 1

Interventions

Gemcitabine 56 Paclitaxel 50 Cyclophosphamide 44 pembrolizumab 42 Carboplatin 41 Bevacizumab 38 Cisplatin 33 Docetaxel 31 Fluorouracil 30 Nivolumab 29 Capecitabine 29 Pemetrexed 24 Irinotecan 24 Oxaliplatin 23 Ipilimumab 22 Dexamethasone 22 Leucovorin 21 Radiotherapy 20 Sorafenib 19 Doxorubicin 19 Everolimus 18 Cetuximab 18 fludarabine 17 Albumin-Bound Paclitaxel 17 trametinib 15 Sunitinib 15 Rituximab 15 Erlotinib Hydrochloride 15 Prednisone 14 Fulvestrant 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01806129 2025-06-13

EROS

Eastern Cooperative Oncology Group

Phase NA Active not recruiting

434 enrolled 9 charts

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡